🔎 Trials Near Me

Hjem › Polycytemia vera › California

Kliniske studier for Polycytemia vera i California

6 studier for Polycytemia vera søker deltakere på steder i California.

Byer i California

Offisiell studietekst (engelsk)

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  • UCLA Ronald Reagan Medical Center, Los Angeles
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • Stanford Cancer Institute Palo Alto, Palo Alto
  • og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06661915

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • City of Hope-Lennar Foundation Cancer Center, Irvine
  • Usc Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Medical Hematology & Oncology, Los Angeles
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07441694

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06063486

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

  • Emad Ibrahim, MD, Inc, Redlands
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. mar. 2026 · NCT06093672

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

  • University of California, Irvine, Irvine
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 10. mar. 2026 · NCT05123365

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.